Physician profile
Bryan L Nelson
NPI 1346265477
$1,552.65
in general payments reported to CMS, 2019-2025
26 companies · $256 in 2025
The $256 reported for 2025 was more than what 81% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $299 · 2020: $82.49 · 2021: $163 · 2022: $165 · 2023: $315 · 2024: $272 · 2025: $256.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $843.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $843.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $559.56 | 2019-2025 | |
| Glaxosmithkline, LLC. | $123.97 | 2019-2025 | Bexsero, Arexvy, Shingrix |
| Dynavax Technologies Corporation | $107.82 | 2019-2024 | Heplisav-B |
| Lilly USA, LLC | $98.72 | 2019-2024 | Mounjaro, Jardiance, Trulicity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $97.58 | 2019-2022 | |
| Gilead Sciences, INC. | $63.06 | 2019-2025 | |
| Amgen INC. | $61.51 | 2019-2025 | Krystexxa, Repatha |
| Merck Sharp & Dohme LLC | $56.64 | 2019-2025 | Capvaxive, Gardasil 9, M-M-R II |
| Quidel Corporation | $40.85 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $37.08 | 2019-2023 | Breztri |
| Biohaven Pharmaceuticals, INC. | $34.46 | 2021 | |
| Medtronic, INC. | $30.20 | 2024-2025 | Inceptiv, Intellis Adaptivestim |
| Pfizer INC. | $27.34 | 2021-2023 | |
| Dexcom, INC. | $23.12 | 2024 | Dexcom G6 Transmitter |
| Alkermes, INC. | $22.41 | 2023 | Vivitrol |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $18.95 | 2025 | Wegovy |
| Treace Medical Concepts, INC. | $18.60 | 2024 | |
| Si-Bone, INC. | $18.03 | 2025 | |
| Boston Scientific Corporation | $17.69 | 2020 | |
| Sonex Health, INC. | $16.64 | 2025 | Sx-One Microknife |
| Takeda Pharmaceuticals U.S.A., INC. | $14.98 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.58 | 2022 | |
| Endo Pharmaceuticals INC. | $13.39 | 2019 | |
| Axonics, INC. | $13.20 | 2022 | |
| Seqirus USA INC | $11.17 | 2019 | |
| Corium, LLC | $11.10 | 2024 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.